p27Kip1
- 1 March 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 14 (3) , 819-822
- https://doi.org/10.1097/01.asn.0000057518.58420.e4
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- The Hypertrophic Effect of Transforming Growth Factor-β is Reduced in the Absence of Cyclin-Dependent Kinase-Inhibitors p21 and p27Journal of the American Society of Nephrology, 2002
- The cyclin kinase inhibitor p21WAF1/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathyKidney International, 1999
- Molecular mechanisms of diabetic renal hypertrophyKidney International, 1999
- Cell cycle inhibitors (p27Kip1 and p21CIP1) cause hypertrophy in LLC-PK1 cellsKidney International, 1999
- Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27Kip1Journal of Clinical Investigation, 1999
- Glomerular expression of p27Kip1 in diabetic db/db mouse: Role of hyperglycemiaKidney International, 1998
- Cellular events in the evolution of experimental diabetic nephropathyKidney International, 1995
- Cyclin dependent kinase regulationCurrent Opinion in Cell Biology, 1995
- High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-βKidney International, 1992
- The biology of renal hypertrophyKidney International, 1986